Drugmaker Takeda to zoom in on emerging markets
Singapore
ASIA'S largest drugmaker Takeda Pharmaceutical has streamlined its Singapore operations in a move that reflects its focus on emerging markets.
Its new Biopolis office, costing an undisclosed sum, will now house its emerging-markets business unit headquarters that was previously based in Zurich, as well as its regional research and development centre and its vaccine business unit.
TRENDING NOW
SIA sinks into the red with S$76 million Q1 loss as fuel costs jump
15-month wait-out curb lifted for private property owners buying HDB resale flats
ABSD deadline extended to up to 7 years for developers of large en bloc sites to encourage reuse of land
A ‘shadow bank’ hiding in Singapore’s Little India casts light on financial services gap